Burstein Jennifer 4
4 · Stoke Therapeutics, Inc. · Filed Jun 5, 2020
Insider Transaction Report
Form 4
Burstein Jennifer
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2020-06-03+14,777→ 14,777 totalExercise: $26.53Exp: 2030-06-02→ Common Stock (14,777 underlying)
Footnotes (1)
- [F1]The option shall fully vest on June 3, 2021 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date.